Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Revenue | 489M | 378M | 256M | 192M |
| Cost of revenue | 134M | 81M | 53M | 40M |
| Research and development | 12M | 12M | 6M | 6M |
| Selling, general and administrative | 58M | 39M | 31M | 27M |
| Operating income | 332M | 176M | 158M | 91M |
| Pre-tax income | 205M | 85M | 126M | 51M |
| Income tax | 44M | 18M | 28M | 13M |
| Net income | 161M | 67M | 98M | 38M |
| Earnings per share | 1.07 | 0.37 | 0.61 | 0.25 |
| Earnings per share, diluted | 1.00 | 0.36 | 0.57 | 0.25 |
| Weighted average shares | 124M | 118M | 116M | 97M |
| Metric | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 528M | 387M | 404M | 194M | 266M |
| Receivables | — | 95M | 51M | 43M | — | — |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Operating cash flow | 283M | 255M | 192M | 90M |
| Depreciation and amortisation | 150M | 109M | 66M | 42M |
| Share-based compensation | 10M | 8M | 5M | 9M |
| Capital expenditure |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| Current assets | — | 1.10B | 708M | 665M | — | — |
| Property, plant and equipment | — | 6.28B | 3.70B | 2.95B | — | — |
| Total assets | — | 8.63B | 5.55B | 4.63B | — | — |
| Current liabilities | — | 1.63B | 592M | 583M | — | — |
| Short-term debt | — | 884M | 212M | 325M | — | — |
| Total liabilities | — | 6.63B | 4.11B | 3.20B | — | — |
| Equity | — | 1.99B | 1.44B | 1.44B | 1.05B | 757M |
| 1.81B |
| 899M |
| 731M |
| 656M |
| Investing cash flow | −2.18B | −929M | −786M | −820M |
| Financing cash flow | 2.01B | 671M | 801M | 685M |